<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We investigated whether pre-treatment with <z:chebi fb="9" ids="16796">melatonin</z:chebi>, a potent free radical scavenger and <z:chebi fb="11" ids="22586">antioxidant</z:chebi>, would protect against permanent focal <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> without reperfusion in a rat middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> (MCAO) model </plain></SENT>
<SENT sid="1" pm="."><plain>A single dose of <z:chebi fb="9" ids="16796">melatonin</z:chebi> at 5, 15, or 50 mg/kg or the vehicle alone was given via an intraperitoneal injection at 0.5 h before permanent MCAO </plain></SENT>
<SENT sid="2" pm="."><plain>Relative infarction volumes on day 3 were significantly reduced in the groups treated with <z:chebi fb="9" ids="16796">melatonin</z:chebi> at 5 (mean+/-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SEM</z:e>, 17.0+/-6.5%), 15 (18.1+/-5.8%), or 50 (20.6+/-5.0%) mg/kg when compared with the vehicle-treated group (37.1+/-2.8%) and so <z:chebi fb="9" ids="16796">melatonin</z:chebi> treatment achieved a relative reduction in <z:mpath ids='MPATH_124'>infarct</z:mpath> volume by 54.2, 51.2 and 44.5%, respectively </plain></SENT>
<SENT sid="3" pm="."><plain><z:chebi fb="9" ids="16796">Melatonin</z:chebi> did not affect the hemodynamic parameters </plain></SENT>
<SENT sid="4" pm="."><plain>Thus, pre-treatment with <z:chebi fb="9" ids="16796">melatonin</z:chebi> at a dose between 5 and 50 mg/kg protects against focal <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> without reperfusion </plain></SENT>
</text></document>